Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A ordinary shares, par value US$0.0001 per share
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
95,310
-
Shares change
-
-1,236,682
-
Total reported value, excl. options
-
$219,214
-
Value change
-
-$2,205,244
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$2.30
Significant Holders of iHuman Inc. - Class A ordinary shares, par value US$0.0001 per share (IH) as of Q3 2024
10 filings reported holding IH - iHuman Inc. - Class A ordinary shares, par value US$0.0001 per share as of Q3 2024.
iHuman Inc. - Class A ordinary shares, par value US$0.0001 per share (IH) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95,310 shares
.
Largest 10 shareholders include CITADEL ADVISORS LLC (38,369 shares), MORGAN STANLEY (19,875 shares), RHUMBLINE ADVISERS (11,390 shares), TWO SIGMA SECURITIES, LLC (11,150 shares), Credit Agricole S A (10,000 shares), UBS Group AG (4,526 shares), STATE STREET CORP (0 shares), Qube Research & Technologies Ltd (0 shares), Arisaig Partners (Asia) Pte Ltd. (0 shares), and XTX Topco Ltd (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.